OssDsign® Spine Registry Study ("Propel")
- Conditions
- Degenerative Disc DiseaseSpinal Stenosis
- Registration Number
- NCT05329129
- Lead Sponsor
- OssDsign
- Brief Summary
The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.
- Detailed Description
This multi-center study (up to 15 US study sites) is a post market, prospective, observational spine fusion registry. The outcomes of patients undergoing spine fusion with OssDsign® bone grafts will be documented and evaluated for the purposes of post market clinical follow up as part of OssDsign® post market surveillance activities. The length of study duration and number to be recruited is open-ended but initially a target of 450 subjects will be recruited and followed up for a period of 24 months ± 90 days after their index surgery in which an OssDsign® bone graft has been implanted.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 450
Not provided
- Patients not meeting all of the inclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of bone fusion 12 months ± 60 days post-operative examination Assessment of the rate of bone fusion via Computerized Tomography (CT)/x-ray based on evidence of continuous bone bridging from the superior to the inferior vertebral body at the target level.
- Secondary Outcome Measures
Name Time Method Presence of bone fusion 6, 12 and 24 months All subjects will undergo x-ray evaluation to include AP and neutral lateral views pre-operatively. At post-operative visits AP and neutral lateral x-rays, plus flexion and extension x-rays (if standard care) taken with the subject standing up and/or a CT scan taken.
Quality of Life Questionnaire: Oswestry Disability Index Up to 4 months, 6, 12 and 24 months A questionnaire used to measure a patient's permanent functional disability scored 0-4, (no disability) to 35-50, (completely disabled).
Quality of Life Questionnaire: Visual Analog Scale (VAS) Up to 4 months, 6, 12 and 24 months A self rated pain scale from 0 (no pain) to 10 (worst imaginable pain)
Quality of Life Questionnaire: Short Form 36 (SF-36) Up to 4 months, 6, 12 and 24 months A Questionnaire used to measure the impact of clinical and social interventions using eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability
Quality of Life Questionnaire: Neck Disability Index (NDI) Up to 4 months, 6, 12 and 24 months A self-reported questionnaire to determine how pain affects everyday life and assess the level of disability and scored from 0 (no disability) to 50 (complete disability).
Safety review of device related AE's Throughout study, 24 months Review of Adverse Events
Neurological Function Up to 4 months, 6, 12 and 24 months All subjects will be assessed for sensory, reflex, and muscle strength (motor) by the clinician
Trial Locations
- Locations (13)
Community Health Partners Neuroscience
🇺🇸Fresno, California, United States
San Diego Neurosurgery
🇺🇸San Diego, California, United States
Orthopedic Associates of Hartford
🇺🇸Hartford, Connecticut, United States
Central Connecticut Neurosurgery and Spine
🇺🇸New Britian, Connecticut, United States
Yale Center for Clinical Investigation, Yale School of Medicine
🇺🇸New Haven, Connecticut, United States
Minimally Invasive Spine Center of South Florida
🇺🇸Miami, Florida, United States
Foundation for Orthopaedic Research and Education
🇺🇸Tampa, Florida, United States
Northeast Georgia Medical Center
🇺🇸Gainesville, Georgia, United States
Carle Foundation Hospital, NeuroScience Institute
🇺🇸Urbana, Illinois, United States
Orthopaedic Institute of Western Kentucky
🇺🇸Paducah, Kentucky, United States
Scroll for more (3 remaining)Community Health Partners Neuroscience🇺🇸Fresno, California, United StatesAllyssa Gomez, CRCContactAGomez6@communitymedical.orgDerek Taggard, MDPrincipal Investigator